Fundz

Second Sight Medical Products Inc reported raising $3 Million in an initial SEC Form D filing, from an offering of $3 Million

PUBLIC · VANIDec 21, 2018

Amount Raised

$3 Million

$3 Million sold, per SEC Form D (first sale Dec 21, 2018)

Round Type

Seed

SylmarBiotechnologyHealthcareHealth CarePharmaceuticalBiopharma

Quick answer

Vivani Medical, Inc. raised $3 Million in a Seed round, dated December 21, 2018. Vivani Medical, Inc. is based in Sylmar, California, United States.

How much did Vivani Medical, Inc. raise?
Vivani Medical, Inc. raised $3 Million in a Seed round on December 21, 2018.
What does Vivani Medical, Inc. do?
Vivani Medical, Inc. is an innovative, preclinical-stage biopharmaceutical company focused on developing novel, long-term drug implants leveraging its proprietary NanoPortal™ platform.
Where is Vivani Medical, Inc. based and how big is it?
Vivani Medical, Inc. is based in Sylmar, California, United States.

Source: Fundz verified event record.

Who else raised in Healthcare and Pharmaceutical around the same time

Companies in the same sectors as Vivani Medical, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • vTv Therapeutics Inc. raised $1.5M (Seed) on January 4, 2019.
  • Ionetix Corp raised $27M on December 21, 2018.
  • Amylyx Pharmaceuticals raised $13M on November 20, 2018.
  • Tellus Therapeutics raised $75K (Pre-Seed) on January 31, 2019.
  • SPR Therapeutics raised $8M on January 30, 2019.
  • Purple Biotech raised $6M on January 24, 2019.

Who to call at Vivani Medical, Inc., and when

A new round usually means Vivani Medical, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Vivani Medical, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Vivani Medical, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Vivani Medical, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Vivani Medical, Inc.

Location

12744 SAN FERNANDO ROAD SUITE 400

Sylmar, California, United States

About

Vivani Medical, Inc. is an innovative, preclinical-stage biopharmaceutical company focused on developing novel, long-term drug implants leveraging its proprietary NanoPortal™ platform. The company's lead programs NPM-115 and NPM-119 are miniature, six-month, GLP-1 implants in development for the treatment of chronic weight management in obese or overweight patients and type 2 diabetes, respectively.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Vivani Medical, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Vivani Medical, Inc.'s next move

See what Strategic adds

Vivani Medical, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.